Wordt geladen...
Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
BACKGROUND: Determining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment of neuroblastoma cure. METHODS: In this study, we examined the cytogenetic and tumorigenic physiognomies of distinct population o...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4496850/ https://ncbi.nlm.nih.gov/pubmed/26159519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1463-y |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|